Loading...
  • CD34
  • PBSCs are processed in vitro for enrichment of CD34 cells and transduced with a Fanconi's anemia complementation C (FACC) retroviral vector on days 5-10. (clinicaltrials.gov)
  • renal
  • Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab. (iu.edu)
  • radiation
  • Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer. (nih.gov)
  • Holmium Ho 166 DOTMP may deliver radiation directly to cancer cells and cause less damage to normal tissue. (clinicaltrials.gov)
  • Autoimmune
  • Fassas A, Passweg JR, Anagnostopoulos A, et al, for the Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). (springer.com)
  • Autoimmune hemolytic anemia or pure red cell aplasia, AIHA: Hemolytic anemia Hemoglobin less than 10.0 g/dL without transfusion Hemolysis as evidenced by both: Sustained reticulocytosis (greater than 125,000/mm3) without evidence of active bleeding or increasing hemoglobin Laboratory evidence of hemolysis Positive direct antiglobulin test or equivalent immune adherence test No evidence for paroxysmal nocturnal hemoglobinuria Negative Ham's test and sucrose hemolysis. (clinicaltrials.gov)
  • harvest
  • However, in autologous transplants, the harvest failure rates are high because of inadequate mobilization using G-CSF alone. (springer.com)
  • suppresses
  • Reduced-intensity conditioning kills some cancer cells and somewhat suppresses your immune system. (mayoclinic.org)
  • Suppresses some humoral immunity and more so cell-mediated immune reactions. (medscape.com)
  • Suppresses hypersensitivities of cell-mediated type and variably alters antibody production. (medscape.com)